TYMLOS "Osteoferocious" Campaign

​

TYLMOS is a bone-building (anabolic) medication for women with postmenopausal osteoporosis at high risk for fracture. The brand launched in 2017 against steep competition. We knew we needed something bold and breakthrough in order to cut through the clutter—and to better connect with women over 50 who are still active, working and in the prime of their life. Click on an icon below to see more from the TYMLOS "Osteoferocious" campaign. (And while I sadly cannot take credit for the brilliant campaign name, all featured work on this launch brand is mine.)